3D Bioprinting: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claim Analysis)

  • Lowest Price Guaranteed From USD 1,899

  • Published
    January 2023

  • Slides
    185

  • View Count
    132

Example Insights

3D-Bioprinting-IP-Landscape-Context-thumb 3D-Bioprinting-IP-Landscape-Historical-Trend-thumb 3D-Bioprinting-IP-Landscape-Distribution-by-Kind-Code-thumb 3D-Bioprinting-IP-Landscape-Relevant-Prior-Art-Search-Expressions-thumb
3D-Bioprinting-IP-Landscape-Key-IP-Trends-thumb 3D-Bioprinting-IP-Landscape-Key-Areas-of-Innovation-thumb 3D-Bioprinting-IP-Landscape-Patentability-and-Freedom-to-Operate-thumb 3D-Bioprinting-IP-Landscape-Patent-Valuation-Analysis-thumb
3D-Bioprinting-IP-Landscape-Claim-Analysis-thumb 3D-Bioprinting-IP-Landscape-Key-Pockets-of-Innovation-thumb 3D-Bioprinting-IP-Landscape-White-Spaces-in-Innovations-thumb 3D-Bioprinting-IP-Landscape-Overview-of-Excel-Deliverable-thumb
3D-Bioprinting-IP-Landscape-3D-bioprinting-IP-dataset-thumb      

Overview

Tissue injury and dysfunctioning commonly occurs in humans; however, not in all cases, the tissue regeneration capability of a human body is able to cope up with the damage caused. The conventional approach used to deal with this type of trauma involves transplantation of damaged tissues or organs; this is further associated with several limitations, including non-availability of compatible organ donor, risk of graft rejection (due to the body’s immunological reaction) and post-surgical infection / complication. Another tissue engineering approach involves the amalgamation of cells, biomolecules and growth factors with scaffolds, in order to develop a three-dimensional (3D) functional tissue that mimics the human tissue. However, this technique is less effective, time consuming and can lead to non-homogenous distribution of cells in the matrix, making it logistically and financially non-feasible for clinical applications. To improve on this aspect, additive manufacturing, specifically 3D bioprinting, is being explored in the tissue engineering domain. The 3D bioprinting technique employs bioinks (consisting of living cells and biomaterials) to fabricate complex anatomical structures (tissues, cartilages and organs), in a layer-by-layer pattern, with the help of computer-aided printers. Further, 3D bioprinting offers a range of benefits over the conventional tissue engineering techniques, including high accuracy, enhanced resolution, fast processing time and low cost. Owing to the layer-wise construction, bioprinted tissues consist of pores, which promote easy perfusion of gas and nutrients, as well as enable intercellular and intracellular communication. It is worth mentioning that Organovo was the first company to enter the 3D bioprinting space by printing functional blood vessels in 2010.

Despite the various advantages associated with 3D bioprinting, the technology is associated with certain challenges. One of the key challenges is the stringent requirement to maintain the quality across each step (designing the model, selection of the bioink, printing validation and post-printing) executed before the transplantation. Further, the lack of a robust design software might hamper the manufacturing of a mechanically stable 3D construct. In this regard, various industry stakeholders and academicians have undertaken initiatives in order to further develop / improve this technology for use across a variety of applications, including fabrication of bone, cartilage, organ and skin (for transplantation), drug testing, toxicology screening, and cancer research, by using diseased tissue models. As a result, the intellectual capital related to different 3D bioprinting techniques, such as extrusion bioprinting, inkjet printing, laser assisted bioprinting and stereolithography, has also grown. In light of such developments, it is important to keep track of both pockets of innovation and key areas of improvement for stakeholders to remain competitive in this upcoming field of the healthcare domain. This report captures some of the key R&D-related trends and provides competitive intelligence on the intellectual property in the field of 3D bioprinting.

Scope of the Report

The “3D Bioprinting: Intellectual Property Landscape” report features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of 3D bioprinting. The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain. Key inclusions are briefly described below:

  • Overall Intellectual Property Landscape
    An analytical perspective of the various patents and affiliated IP documents that have been published related to 3D bioprinting, since 2000. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this niche, yet rapidly evolving applications in the biotechnology and pharmaceutical industry.
  • Popular / Relevant Prior Art Search Expressions
    An examination of IP literature, shortlisting key words and phrases used to describe 3D bioprinting. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms (which can be used to identify other relevant IP search terms and establish relationships between prior art search expressions), and other related trends.
  • Patent Valuation Analysis
    A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in value associated with the gross domestic product (GDP) of a particular region).
  • Patentability and Freedom to Operate
    A systematic approach to identify relevant areas of innovation by analyzing published IP documents (representative of unique patent families), by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP. 
  • Analysis of Patent Applications
    A detailed summary of the various patent applications (representative of unique patent families) that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation (such as a product class, enabling technologies or method of use), thereby, offering the means to identify active arenas of research and assess innovation-specific IP filing trends.
  • Analysis of Granted Patents
    An analysis of the granted patents (representative of unique patent families) across different global jurisdictions and their relative value in the IP ecosystem. The analysis also features a meaningful classification system, segregating granted IP into relevant categories (namely type of innovation and innovation) to help develop a detailed perspective on the diversity of intellectual capital (having marketing exclusivity) related to 3D bioprinting, and the assessing likelihood for innovators to enter into promising research areas. 
  • Pockets of Innovation and White Spaces
    An insightful analysis of the various CPC codes used in published IP literature (representative of unique patent families) and their affiliated families, offering the means to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic IP classification approach, mentioned earlier); the analysis also features a discussion on prevalent white spaces (based on type of innovation and innovation in this field of research.
  • Claim Analysis
    One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents (representative of unique patent families) in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent (product patent or method patent), type of claim (open ended claim or closed ended claim) and key elements of a claim (individual aspects of an innovation that are covered in a singular claim).

Contents

DELIVERABLE OUTLINES

Excel Deliverable

Sheet 1 features details related to how the input data for this project was collated, including the search strings used to query a popular patent database (lens.org), and data segregation notes. 

Sheet 2 is a summary MS Excel dashboard, offering a detailed, graphical perspective of the intellectual property landscape of 3D bioprinting. It includes pictorial representations of the overall patent landscape, IP documents representing patent families that describe unique innovations related to 3D bioprinting, trends related to patent applications (including insights on patentability and freedom to operate), trends related to granted patents (including insights on patentability and freedom to operate), key inferences from a proprietary claim analysis, list of popular CPC symbols (featuring key pockets of innovation) and list of popular applicants (shortlisted based on number of published IP documents).
    
Sheet 3 is an elaborate tabular representation of the overall IP landscape, featuring information on the various types of IP documents, related to 3D bioprinting, which have been published since 2000. 

Sheet 4 is an excerpt of the data presented in the previous sheet, featuring published IP documents, that represent unique patent families across various global jurisdictions. This dataset has been analyzed in detail, in the report. 

Sheet 5 includes a tabular representation of the key words and phrases (prior art search expressions) that are used to describe 3D bioprinting and affiliated intellectual capital.

Sheet 6 is a subset of sheet 4, featuring all the patent applications, covering innovations related to 3D bioprinting.

Sheet 7 is a subset of sheet 4, featuring all the granted patents, covering innovations related to 3D bioprinting. 

Sheet 8 is an insightful summary of the key inferences from the independent claims of the granted, active patents in the dataset. It involves the use of a systematic segregation approach to analyze key trends associated with the preamble, type of patent (product patent or method patent), type of claim (open ended claim or closed ended claim) and key elements of a claim (individual aspects of an innovation that are covered in a singular claim).

Sheet 9 provides insights related to some of the key applicants that are active in this field of research, featuring company-specific details (such as year of establishment, and location of headquarters), and inputs on their respective IP publication trends. 
    
Sheet 10 features an analysis of the most popular CPC symbols and CPC families (in terms of frequency of appearance in the dataset), related to 3D bioprinting. 

Sheet 11 is an appendix, which includes pivot tables that drive the charts and interactive elements for the complete IP landscape depicted in sheet 2 of the deliverable.

Sheet 12 is an appendix, featuring details related to the categorization done in the report, and important abbreviations used in reference to the data categories mentioned in the document.

PowerPoint Deliverable

Chapter 1 briefly describes of the rising demand of compatible organs for transplantation and the key advantages 3D bioprinting. Further, it provides an overview of the intellectual property landscape related to 3D bioprinting. 

Chapters 2 and 3 feature brief (pictorial) summaries of the approach used during data collection for this project, and the key objectives of the study.

Chapter 4 is an executive summary of the important insights and key takeaways, generated from analyzing the IP landscape of 3D bioprinting.

Chapter 5 offers a brief description on 3D bioprinting and its associated technologies. Further, it provides a summary of the important milestones in this field of research, highlighting some of the distinguishing features of both early research and modern variants of such interventions. The chapter highlights the advantages of 3D bioprinting, as well as discusses the application areas and future perspectives associated with this domain.

Chapter 6 includes a review of the various patents and affiliated IP documents that have been published related to 3D bioprinting, since the year 2000. It also features an in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, and includes insightful inferences related to both historical and recent R&D trends within this niche, yet rapidly evolving applications the healthcare segment.

Chapter 7 features an insightful examination of IP literature, highlighting key words and phrases that are used to describe 3D bioprinting, including information on historical usage in IP filings, key affiliated terms (which can be used to identify other relevant IP search terms and establish relationships between prior art search expressions), and other related trends.

Chapter 8 offers insights from a competitive benchmarking and valuation analysis of the key members of unique patent families that have been captured in the report. It takes into consideration important parameters, such as type of IP document, year of application, time to expiry, number of citations and jurisdiction (factoring in value associated with the gross domestic product (GDP) of a particular region).

Chapter 9 provides a detailed summary of the patent applications (representative of unique patent families) that were filed across different jurisdictions and their relative value in the IP ecosystem. The analysis segregates the captured intellectual capital in terms of type of innovation and the specific innovation (different product classes, enabling technologies or methods of use), thereby, offering the means to identify active arenas of research and assess innovation-specific IP filing trends. Further, it features an analysis that helps identify relevant areas of innovation by analyzing published IP documents (representative of unique patent families), defining the uniqueness of patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions where new and / or modified claims may be filed without infringing on existing IP.

Chapter 10 is an elaborate summary of the granted patents (representative of unique patent families) across different global jurisdictions and their relative value in the IP ecosystem. The analysis also features a meaningful classification system, segregating granted IP into relevant categories (namely type of innovation and innovation) in order to help develop a detailed perspective on the diversity of intellectual capital (having marketing exclusivity) related to 3D bioprinting and assessing the likelihood for innovators to enter into promising product markets, once active patents expire. Further, it features an analysis that helps identify relevant areas of innovation by analyzing published IP documents (representative of unique patent families), defining the uniqueness of patented innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions where new and / or modified claims may be filed without infringing on existing IP.

Chapter 11 features profiles of some of the most popular applicant companies, which were shortlisted based on their respective patent filing activities. Each profiles includes a brief overview of the company, information on annual revenues (wherever available), details on its 3D bioprinting related initiatives, names of key management team members and recent developments. 

Chapter 12 includes an insightful analysis of the various CPC symbols mentioned in published IP literature (representative of unique patent families) and their affiliated families, offering the means to identify historical and existing pockets of innovation (based on the functional area / industry described by the elaborate and systematic IP classification approach, mentioned earlier); the analysis also features a discussion on prevalent white spaces (based on innovation and innovation types) in this field of research.

Chapter 13 concludes the report by summarizing publicly available insights on the anticipated developments in this domain (taking into consideration the perspectives of eminent representatives of stakeholder companies in this industry), and trends that are likely to shape the future of 3D bioprinting. 

Chapter 14 is a set of appendices, entailing an overview of the excel research report, a list of IP documents featuring the identified white spaces, table of contents, list of figures, list of tables, glossary, and list of all the applicant companies and organizations.

Table Of Contents

Excel Deliverable

1. Research Notes

2. Summary Dashboard
A. Overall Intellectual Property Landscape
B. Intellectual Property Landscape (Grouped by Simple Families)
C. Key Prior Art Search Expressions
D. Key Trends related to Patent Applications (featuring Patentability and Freedom to-Operate)
E. Key Trends related to Granted Patents (featuring Patentability and Freedom-to-Operate)
F. Claims Analysis
G. Key CPC Symbols
H. Key Applicants

3. Overall Intellectual Property Landscape Dataset

4. Prior Art Search Expressions (Keyword Analysis)

5. Patent Applications Dataset

6. Granted Patents Dataset

7. Claims Analysis

8. Key Applicants Analysis

9. CPC Analysis

10. Appendix I: Pivot Tables

11. Appendix II: Country / Geography Codes

12. Appendix III: Innovation Categories

PowerPoint Deliverable

1. Context

2. Project Approach

3. Project Objectives

4. Executive Summary

5. 3D Bioprinting
5.1. Overview
5.2. 3D Printing Process
5.3. Key Historical Milestone
5.4. Advantages, Key Application Areas and Future Perspective of 3D Bioprinting

6. Overall Intellectual Property Landscape
6.1. Overview
6.2. Analysis of Simple Patent Families
6.3. Key Innovation Categories
6.4. Insights from Patent Applications
6.5. Insights from Granted Patents

7. Key Prior Art Search Expressions
7.1. Overview
7.2. Analysis of Prior Art Search Expressions

8. Intellectual Property Valuation Analysis
8.1. Valuation Overview
8.2. Analysis of Individual Value Ranks
8.2.1. Rank 1 IP Documents
8.2.2. Rank 2 IP Documents
8.2.3. Rank 3 IP Documents
8.2.4. Rank 4 IP Documents
8.2.5. Rank 5 IP Documents
8.3. Concluding Remarks
8.4. List of Rank 1 IP Documents

9. Analysis of Patent Applications
9.1. Overview
9.2. Relative Valuation of Patent Applications
9.3. Patentability and Freedom-to-Operate

10. Analysis of Granted Patents
10.1. Overview
10.2. Relative Valuation of Grated Patents
10.3. Patentability and Freedom-to-Operate
10.4. Analysis of Patent Claims (Granted Active Patents)

11. Key Applicants
11.1. Overview
11.2. Analysis of Key Applicants
11.2.1. Company A
11.2.2. Company B
11.2.3. Company C
11.2.4. Company D
11.2.5. Company E
11.2.6. Company F
11.2.7. Company G
11.2.8. Company H
11.2.9. Company I
11.2.10. Company J

12. Pockets of Innovation and White Spaces
12.1. Overview
12.2. Pockets of Innovation
12.3. White Spaces
12.4. Concluding Remarks

13. Future Outlook
13.1. 3D Bioprinting: IP Filing Growth Trends
13.2. Relevance of IP for Business Development and Growth
13.3. Contemporary Sentiments and Predictions
13.4 Anticipated Future Developments and Trends

14. Appendices

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report:

  1. 1LAB SA
  2. 3D Bio-Tissues
  3. 3D Systems
  4. 3DTech Oy
  5. 525 Solutions
  6. Aalto University 
  7. Aarhus University
  8. Accelerated Biosciences
  9. Accurate International 
  10. Acupharm 
  11. ADA Science & Research Institute
  12. Advanced BioMatrix
  13. Advanced Solutions Life Sciences
  14. Agency for Science, Technology and Research (A*STAR)
  15. Agilent Technologies
  16. Aix-Marseille University
  17. AJL Ophthalmic
  18. Ajou University 
  19. Albert Ludwig University of Freiburg
  20. Aleph Farms
  21. ALGAKTIV
  22. Allegro 3D
  23. Allergan
  24. Allevi
  25. AlloSource
  26. Alpha Tech 
  27. Alpvision
  28. Amferia
  29. ANPOLY
  30. Anthrogenesis
  31. Ants Innovate
  32. AO Tech
  33. Applied Materials
  34. Arizona State University
  35. Arizona State University 
  36. Arkema
  37. Arrayjet
  38. Arrayon Biotechnology
  39. ASAN Foundation 
  40. Aspect Biosystems
  41. ATES 
  42. Auburn University 
  43. Auregen BioTherapeutics
  44. Aurelia Bioscience
  45. Autodesk
  46. Axenoll Life Sciences
  47. Axial Medical Printing
  48. Baobab Healthcare
  49. Barcelona Science Park
  50. Bar-Ilan University 
  51. Batu Biologics
  52. Baylor College of Medicine
  53. BC Genesis
  54. Berlin Institute of Technology
  55. Beth Israel Deaconess Medical Center
  56. BICO
  57. Bioalpha 
  58. BioBots  
  59. Biogelx
  60. BiologIC Technologies
  61. Biome Renewables
  62. Biom'up
  63. Bioprint
  64. Bio-ReCell
  65. BioSapien
  66. Biostage
  67. Blafar
  68. Bloxton Investment Group
  69. BlueNalu
  70. Bone Sci Bio
  71. Bordeaux University Foundation
  72. Boston University
  73. Brahma Holdings
  74. Bridgestone Americas Tire Operations
  75. Brigham and Women’s Hospital
  76. Brinter Oy 
  77. Brown University 
  78. BSH Electrodomésticos
  79. BSH Hausgeräte
  80. Byon
  81. Cairn Biosciences
  82. Cambridge Innovation Technologies Consulting
  83. Carbitex
  84. Carbon 
  85. Carbon Design Innovations
  86. Carcinotech
  87. Carl Zeiss Meditec
  88. Carnegie Mellon University
  89. Carol Davila University of Medicine and Pharmacy 
  90. Case Western Reserve University
  91. Catalan Institution for Research and Advanced Studies (ICREA)
  92. Catholic University of America
  93. Catholic University of Korea School of Medicine
  94. Catholic University of Leuven
  95. Catholic University of Valencia Saint Vincent Martyr
  96. Cedars-Sinai Medical Center
  97. Cellbricks
  98. CELLHEAL 
  99. CELLINK
  100. Cellino Biotech
  101. Cells for Cells
  102. Cellutech
  103. Celularity
  104. Central School of Marseille
  105. Central South University
  106. CGbio 
  107. Changzhou Walter Intelligent Technology
  108. Chastnoe Uchrezhdenie
  109. Children’s Healthcare of Atlanta
  110. China Agricultural University
  111. China Medical University
  112. China Pharmaceutical University
  113. Chinese PLA General Hospital
  114. Chinese University of Hong Kong 
  115. CHL
  116. Chung-Ang University 
  117. Chungbuk National University (CBNU)
  118. CIC biomaGUNE 
  119. Cincinnati Children's Hospital Medical Center
  120. Cirius Therapeutics
  121. Claude Bernard Lyon University
  122. Clear Labs
  123. CLECELL 
  124. Clemson University 
  125. Clemson University Research Foundation (CURF) 
  126. Cleveland State University
  127. Cline Scientific
  128. Collagen Matrix
  129. CollPlant 
  130. Colorado School of Mines
  131. Colorado State University Research Foundation
  132. COLTENE 
  133. Columbia University
  134. Commonwealth Scientific and Industrial Research Organisation (CSIRO)
  135. CommScope
  136. Connecticut Children's Medical Center
  137. Consortium Center for Biomedical Research
  138. Contipro
  139. Copenhagen University
  140. Cornell University
  141. Corning
  142. Cyfuse  
  143. Cytometix
  144. Cytonus Therapeutics
  145. CYTOO
  146. Daegu Gyeongbuk Institute of Science & Technology (DGIST)
  147. Dalian Jiaotong University 
  148. Dalian University of Technology
  149. Dana Farber Cancer Institute
  150. Dartmouth College
  151. DEKA
  152. DePuy Synthes
  153. Dermagenesis Skin & Body Care
  154. DERMYAH Innovations in beauty and wellness
  155. Digilab
  156. Dow 
  157. Dramedica
  158. Dresden University of Technology
  159. Drexel University
  160. Duke University
  161. DuPont's Nutrition & Biosciences
  162. Dutch Research Council
  163. Ear Science Institute Australia
  164. East China University of Science and Technology
  165. East Tennessee State University
  166. Eindhoven University of Technology
  167. ELWHA
  168. Embody
  169. Emory University
  170. Emulate
  171. Engitix
  172. Enrich Therapeutics
  173. Eskisehir Osmangazi University
  174. Esoterix Genetic Laboratories
  175. Establishment Labs
  176. Evonik Industries
  177. Exo Cell
  178. Fashion Institute of Technology
  179. FASOTEC
  180. Federal Polytechnic School of Lausanne (EPFL)
  181. Federal State Autonomous Educational Institution of Higher Education
  182. Fibrothelium
  183. Fidia Farmaceutici
  184. Figene Capital
  185. Fiomet Ventures
  186. Florida State University Research Foundation
  187. Fluicell
  188. FMC BioPolymer
  189. Fond Imagine
  190. Forecast Technology
  191. Foundation on Research and Science Development
  192. Fourth Military Medical University
  193. Free University of Berlin
  194. French Alternative Energies and Atomic Energy Commission
  195. French National Centre for Scientific Research
  196. Fresh Health
  197. Frontier Bio
  198. Fujian Normal University
  199. Fujian Wanchen Biotechnology
  200. FURS
  201. Furukawa Electric Advanced Engineering FUTRFAB
  202. Galderma
  203. GeniPhys 
  204. GenMark Diagnostics
  205. Genzir Technologies
  206. George Washington University 
  207. Georgia Tech Research Institute
  208. Ghent University 
  209. Global Graphene Group
  210. Goethe University
  211. Gold Coast Hospital
  212. Governing Council - University of Toronto
  213. Graduate School of Industrial Physics and Chemistry (ESPCI)
  214. GranBio 
  215. Greenaltech 
  216. Greiner Bio-One North America
  217. Grenoble Alpes University 
  218. Griffith University
  219. GT Medical Technologies
  220. Guangdong Medical University
  221. Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)
  222. Guangxi Medical University
  223. Guangzhou Rainhome Pharm & Tech
  224. Guangzhou Taibao Medical Institute
  225. Guill 
  226. Gwangju Institute of Science and Technology (GIST)
  227. Haining Zhuluoji Biotechnology
  228. Hallym University 
  229. Haltzak BioPharma
  230. HanBio Therapeutics
  231. Hangzhou Dianzi University
  232. Hangzhou Foreland Technology
  233. Hangzhou Jiangnofly Biotechnology
  234. Hangzhou LifeReal Biotechnology
  235. Hangzhou Regenovo Biotechnology
  236. Hanyang University 
  237. Harvard College
  238. Helmholtz Munich
  239. Henan Polytechnic University
  240. Hesperos
  241. HEWLETT PACKARD
  242. Histogenics 
  243. Hkable Biological 3D 
  244. Holo  
  245. Hope City
  246. Hospital of Hefei Institutes of Physical Science, Chinese Academy of Sciences
  247. Houston Methodist Hospital
  248. Huaian Zongheng Bio-Tech
  249. Hubei Polytechnic University
  250. Humeltis 
  251. Hunan University
  252. Hurel 
  253. Huzhou Ancestor Electronic Technology
  254. Hyderabad Eye Research Foundation
  255. Hyundai Motor
  256. IBM
  257. Icahn School of Medicine at Mount Sinai
  258. IDONIAL
  259. iFix Medical
  260. Immunotrex
  261. Imperial College Innovations
  262. Imtek Engineering
  263. In Silico Discovery Research Academic Services (INDRAS)
  264. Indian Institute of Technology Delhi
  265. Indian Institute of Technology Hyderabad
  266. Indiana University 
  267. Indiana University Research & Technology   
  268. Industrial Technology Research Institute
  269. Industry-University Cooperation Foundation Hanyang University (IUCF-HYU)
  270. Industry-University-Research Cooperation Foundation
  271. Infinite  
  272. Inkbit
  273. Innogy Innovation Hub
  274. InnoRegen
  275. Innovative Therapies
  276. InnovoSciences 
  277. InSphero
  278. Institut Curie
  279. Institute for Bioengineering of Catalonia (IBEC)
  280. Institute of Biomedical Engineering (IBME) 
  281. Institute of Chemistry, Chinese Academy of Sciences 
  282. Institute of Genetics and Developmental Biology Chinese Academy of Sciences
  283. Institute of Nuclear Energy Research (INER)
  284. Intellia Therapeutics
  285. Inventia Life Science
  286. Istanbul Medipol University
  287. iThemba
  288. IVIVA Medical
  289. Izumi International
  290. J. Craig Venter Institute (JCVI)
  291. Jiangnan University
  292. Jiangsu University
  293. Jiangxi Booway New Technology
  294. Jiaxing Yaojiao Medical & Development
  295. Johannes Gutenberg University of Mainz
  296. Johns Hopkins University
  297. Jointechlabs 
  298. Kaohsiung Medical University
  299. Karlsruhe Institute of Technology (KIT)
  300. Khalifa University
  301. King AbdulAziz University
  302. King Abdullah University of Science and Technology (KAUST)
  303. Kinpo Electronics
  304. KLS Martin Group
  305. Kobe University
  306. Kookmin University 
  307. Korea Institute of Science and Technology (KIST)
  308. Korea Polytechnic University 
  309. Korea Polytechnic University Industry Academic Cooperation Foundation
  310. Korea Research Institute of Chemical Technology
  311. Korea University
  312. Kubota KK
  313. Kuraray
  314. Kynan Duke IP
  315. Kyndryl
  316. Kyungpook National University
  317. Kyungpook National University Hospital
  318. LabSkin Creations
  319. LacriSciences
  320. Lausanne University Hospital
  321. Lawrence Livermore National Security
  322. Leibniz Institute for New Materials (INM)
  323. Leibniz Institute of Surface Engineering (IOM) 
  324. Leica Microsystems
  325. Leiden University
  326. Leland Stanford Junior University
  327. Lineage Cell Therapeutics
  328. Louisiana State University
  329. Maastricht University
  330. Mannatech
  331. Maoming People's Hospital
  332. Marine Techno
  333. Marmara University
  334. Marquette University
  335. Massachusetts Eye and Ear 
  336. Massachusetts General Hospital
  337. Massachusetts Institute of Technology
  338. Massivit 3D Printing Technologies
  339. Max Planck Society
  340. Mayo Clinic
  341. Mayo Foundation for Medical Education and Research
  342. Mazor Robotics
  343. Mcmaster University
  344. MEATECH 3D
  345. Medical University of Warsaw
  346. Medicinal Bioconvergence Research Center (Biocon)
  347. Medifab
  348. Medispace
  349. Medtronic
  350. Memphis Meats 
  351. Mentor  
  352. Mercer University
  353. Microsoft Technology Licensing
  354. Ministry of Agriculture and Rural Development
  355. Mirae Cell Bio
  356. Miromatrix
  357. Modern Meadow
  358. Molecular Devices 
  359. Monarch Biosciences
  360. Monash University
  361. Monterrey Institute of Technology and Higher Studies
  362. Morphodyne
  363. Mossakowski Medical Research Centre Polish Academy of Sciences
  364. Munich University of Applied Sciences 
  365. Murdoch Children's Research Institute
  366. MUSC Foundation for Research Development
  367. Mycronic
  368. Nagasuna Mayu
  369. Nanjing First Hospital
  370. Nanjing Tech University
  371. Nankai University
  372. Nano Dimension
  373. Nano3D Biosciences
  374. Nanochon
  375. nanoGUNE  
  376. Nanotecmarin
  377. Nanotek Instruments
  378. Nanovis
  379. Nant Holdings
  380. NantBioscience
  381. Nantes University
  382. Nantong University
  383. Nanyang Technological University
  384. NASA
  385. National Dong Hwa University
  386. National Engineering Research Center Nanotechnology (NERCN)
  387. National Healthcare Group 
  388. National Institute of Applied Sciences of Lyon
  389. National Institute of Health and Medical Research (INSERM)
  390. National Institutes of Health (NIH)
  391. National Research & Development Institute for Non-Ferrous and Rare Metals
  392. National Research Council
  393. National School of Arts and Crafts (ENSAM)
  394. National Taiwan University
  395. National Tsing Hua University
  396. National University of Singapore
  397. National Yang Ming University
  398. Natural and Medical Sciences Institute (NMI) 
  399. Nebula Space Enterprise
  400. NEC Solution Innovators
  401. NeoGraft Technologies 
  402. Nestec
  403. Nestlé
  404. New Jersey Institute of Technology
  405. New York Blood Center
  406. NewSouth Innovations
  407. Next Big Innovation Labs
  408. Nippi
  409. Noblis
  410. North Carolina State University
  411. Northeastern University
  412. Northwestern Polytechnical University
  413. Northwestern University
  414. Novadip Biosciences
  415. NovaHep
  416. Novameat
  417. Novartis
  418. Novo Nordisk
  419. Novoheart
  420. NTN 
  421. NUtech Ventures
  422. NuTissu 
  423. Ocean TuniCell
  424. Octet Medical
  425. Ohio State Innovation Foundation
  426. Ohio State University 
  427. Onyel Biotech
  428. Orbillion Bio
  429. Oreal
  430. Oregon Health & Science University
  431. Organes Tissus Regeneration Reparation Remplacement (OTR3)
  432. Organovo
  433. Orgenesis
  434. Orthopedix
  435. Osaka University
  436. Osiris Biomed 3D
  437. Otago Innovation
  438. Ourotech
  439. Oxford Innovation University
  440. P4P 
  441. PA 
  442. Palo Alto Research Center (PARC)
  443. Pandorum Technologies
  444. Paris City University
  445. Paris Diderot University 
  446. Paris Sciences & Lettres University
  447. Paris-East Créteil University
  448. Peking University School of Stomatology
  449. Peking University Third Hospital
  450. Penn State Research Foundation
  451. Pensées
  452. PharmaExceed
  453. Philips
  454. PhoenixSongs Biologicals
  455. Phos Print
  456. PIQUR Therapeutics
  457. Planar Motor
  458. Pohang University of Science and Technology (POSTECH)
  459. Poietis
  460. Polbionica
  461. Poly6 
  462. Polybiomics
  463. Polymer Forge
  464. Polytechnic University of Catalonia
  465. Polytechnic University of Catalonia · Barcelona Tech (UPC)
  466. Pop Test Oncology 
  467. POSCO
  468. Postech Academy - Industry Foundation
  469. Precise Bio
  470. PreComb
  471. Prellis Biologics
  472. Princess Máxima Center for Pediatric Oncology
  473. Princeton University
  474. Prometheus Regeneration R&D
  475. Provenance Bio
  476. Public Assistance–Paris Hospitals
  477. Purdue Research Foundation
  478. Qingdao Unique Products Develop 
  479. Qingdao University
  480. Queen Mary University of London
  481. Queensland University of Technology (QUT)
  482. Readily3D
  483. ReaGene Biosciences 
  484. Regemat 3D S L
  485. REGEN Biocharm
  486. Regen i Göteborg
  487. REGENHU
  488. Regenix
  489. Regenovo
  490. Regents of The University of Michigan
  491. Reprobiogen
  492. Resbiomed
  493. Research Foundation for The State University of New York
  494. Research Foundation of the City University of New York (RFCUNY) 
  495. Resilient
  496. Revotek
  497. Rhine-Westphalia Technical University of Aachen
  498. Rhode Island Hospital
  499. Rice University
  500. Ricoh
  501. RN Tech
  502. Roche Molecular Systems
  503. ROKIT Healthcare
  504. RoosterBio
  505. Rowan University
  506. Royal College of Surgeons in Ireland
  507. Royal Institution For The Advancement Of Learning Mcgill University
  508. Rutgers University
  509. Sabanc? University
  510. Samplix 
  511. Samsung Life Public Welfare Foundation
  512. San Diego State University Research Foundation (SDSURF)
  513. Sanford Burnham Prebys Medical Discovery Institute
  514. Sartorius Stedim Biotech
  515. SC Tech
  516. Schepens Eye Research Institute
  517. School of Advanced Studies in Public Health (EHESP) 
  518. Scienion
  519. SCRIBA Nanotecnologie
  520. Scripps Health
  521. Secant 
  522. Second Affiliated Hospital, Soochow University
  523. Seer 
  524. Seng Enterprises
  525. Seoul National University of Science and Technology
  526. Shaanxi Normal University
  527. Shandong University
  528. Shanghai Institute of Ceramics Chinese Academy of Sciences
  529. Shanghai Jiao Tong University
  530. Shanghai MiFang Electronic Technology
  531. Shanghai Ninth People's Hospital (SNPH)
  532. Shanghai Sixth People's Hospital
  533. Shanghai University
  534. Shanxi Medical University
  535. Shenyang Institute of Automation
  536. Shenzhen Excellent Technology
  537. Shenzhen Institute of Advanced Technology
  538. Shenzhen University
  539. Shenzhen Wingor Biotechnology
  540. Shibuya 
  541. Shinshu University
  542. Sichuan University
  543. Siemens Healthineers
  544. Sightline Innovation
  545. Sigilon Therapeutics
  546. Singapore General Hospital
  547. Singapore Health Services
  548. Singapore University of Technology & Design (SUTD)
  549. Singletto
  550. SinoBioPrint 
  551. Sitex 45
  552. Smithsonian Institute
  553. SMSbiotech
  554. Socovar
  555. Sofia University
  556. Sogang University
  557. SonoVol
  558. Soochow University
  559. Sophion Bioscience
  560. Sorbonne Paris Nord University 
  561. Sorbonne University
  562. Sorbonne University Pierre and Marie Curie Campus
  563. South China University of Technology
  564. South Eastern Sydney Local Health District
  565. Southern Medical University
  566. Southern Methodist University
  567. Southwest Jiaotong University
  568. Spiderwort
  569. Sree Chitra Tirunal Instituteitute for Medical Sciences and Technology
  570. SSenStone
  571. St Vincent’s Hospital
  572. St Vincent’s Public Hospital Melbourne
  573. Stanford University
  574. STC.UNM 
  575. Steelcase
  576. Stemcellago
  577. STENTiT 
  578. Stevens Institute of Technology 
  579. Stora Enso 
  580. Stratasys
  581. Subchondral Solutions
  582. Sumitomo Dainippon Pharma
  583. Sun Yat-sen University
  584. Sunarrow
  585. Sungkyunkwan University
  586. Sunnybrook Research Institute
  587. SunP Biotech
  588. Suzhou Institute of Nano-Tech and Nano-Bionics 
  589. Swansea University
  590. Swedish Algae Factory
  591. Swinburne University of Technology
  592. Symbiox Investment
  593. T&R Biofab
  594. Taiyuan University of Technology
  595. Tan Tock Seng Hospital
  596. TARA Biosystems
  597. TDBT 
  598. Tech Mahindra
  599. Technical Institute of Physics and Chemistry (TIPC)
  600. Technical University of Denmark
  601. Technion Research & Development Foundation
  602. Techshot
  603. Tel Aviv University
  604. Tel Hashomer Medical Research, Infrastructure and Services
  605. Temple University
  606. Tepha
  607. Terasaki Institute 
  608. Tessenderlo 
  609. TeVido BioDevices
  610. Texas A&M University System
  611. The Chinese University of Hongkong (CUHK)
  612. The Council of The Queensland Institute of Medical Research
  613. The Electrospinning Company
  614. The First Affiliated Hospital, Sun Yat-sen University
  615. The Industry & Academic Cooperation (IAC) in Chungnam National University 
  616. The Institute of Genetic and Developmental Biology, China Academy of Sciences
  617. The People's Liberation Army No. 906 Hospital 
  618. The Second People's Hospital of Shenzhen
  619. The Tsinghua Graduate School in Shenzhen
  620. Theradaptive
  621. TheWell Bioscience
  622. Third Xiangya Hospital of Central South University
  623. Tianjin University
  624. TISSIUM
  625. Tissue Bank of France (TBF) 
  626. TissueByNet 
  627. TissueLabs 
  628. TissUse
  629. Tokyo Women’s Medical University
  630. Tongji Medical College 
  631. Toppan
  632. Toray Industries
  633. Triastek
  634. Tsinghua Graduate School
  635. Tsinghua University
  636. Tufts University
  637. U.S. Department of Veterans Affairs
  638. UK Research and Innovation (UKRI)
  639. Ulsan National Institute of Science & Technology
  640. UMC Utrecht Holding 
  641. United States Navy (USN)
  642. United Therapeutics
  643. University College Dublin
  644. University College London
  645. University Hospital of Bordeaux
  646. University Hospital Regensburg
  647. University of Akron
  648. University of Alabama
  649. University of Alberta
  650. University of Arkansas
  651. University of Aveiro
  652. University of Barcelona
  653. University of Bologna 
  654. University of Bordeaux
  655. University of Bristol
  656. University of British Columbia
  657. University of California
  658. University of Cambridge
  659. University of Central Florida Research Foundation
  660. University of Cincinnati
  661. University of Cologne
  662. University of Colorado
  663. University of Connecticut
  664. University of Erlangen–Nuremberg
  665. University of Florida
  666. University of Freiburg 
  667. University of Geneve
  668. University of Glasgow
  669. University of Granada
  670. University of Groningen
  671. University of Illinois
  672. University of Indiana Trustees
  673. University of Iowa Research Foundation
  674. University of Jinan
  675. University of Kansas
  676. University of La Laguna
  677. University of Lausanne
  678. University of Lorraine
  679. University of Los Andes
  680. University of Louisville Research Foundation
  681. University of Maryland
  682. University of Melbourne
  683. University of Memphis
  684. University of Michigan
  685. University of Minnesota
  686. University of Missouri
  687. University of Montana
  688. University of Naples - Chemical, Materials and Industrial Production Engineering
  689. University of Nebraska
  690. University of New York
  691. University of Newcastle
  692. University of North Carolina at Chapel Hill
  693. University of Notre Dame 
  694. University of Oklahoma
  695. University of Otago
  696. University of Ottawa
  697. University of Oxford
  698. University of Pavia
  699. University of Pennsylvania
  700. University of Pisa
  701. University of Pittsburgh
  702. University of Portsmouth 
  703. University of Prince Edward Island
  704. University of Queensland
  705. University of Reims Champagne-Ardenne
  706. University of Rennes
  707. University of Rochester
  708. University of Sheffield
  709. University of South Carolina
  710. University of South Florida
  711. University of Southampton
  712. University of Southern California
  713. University of Sydney
  714. University of Tennessee Research Foundation
  715. University of Texas
  716. University of Texas Health Science Center
  717. University of the Witwatersrand
  718. University of Ulsan 
  719. University of Utah Research Foundation
  720. University of Valladolid
  721. University of Vermont 
  722. University of Virginia Patent Foundation
  723. University of Warmia and Mazury in Olsztyn
  724. University of Washington
  725. University of Wollongong
  726. University of Wuerzburg 
  727. University of Wyoming
  728. UNM Rainforest Innovations
  729. UPM 
  730. URGO 
  731. US Government
  732. US Health
  733. Vanderbilt University
  734. VERIGRAFT
  735. Verrana
  736. Virginia Tech 
  737. VIS 
  738. Viscient Biosciences
  739. Viscofan
  740. VisiCELL Medical
  741. Vital Images
  742. Vivax Bio
  743. Volumetric Biotechnologies
  744. Vox Biomedical
  745. VTT Technical Research Centre of Finland
  746. Wake Forest University
  747. Wannan Medical College
  748. Warsaw Orthopedic
  749. Washington State University
  750. Weinberg Medical Physics
  751. West China Medical Center
  752. Western Union
  753. White Oak Capital Management Consultants
  754. Wisconsin Alumni Research Foundation
  755. Wonkwang University
  756. Worcester Polytech Institute
  757. Wuhan Feng Lin chemical science and Technology
  758. Wuhan Textile University
  759. Wuhan University of Technology
  760. Wuyi University
  761. Xi’An Jiaotong University
  762. Xi’an Polytechnic University
  763. XING Technologies
  764. XYZprinting
  765. Yangzhou University
  766. Yanshan University
  767. Yildiz Technical University
  768. Yissum Research Development
  769. Yokohama City University
  770. Yonsei University
  771. Youjiang Medical University for Nationalities
  772. Zhejiang Ocean University
  773. Zhejiang University
  774. Zhejiang Xunshi Technology
  775. Zhongshan Chaoyang Medical Technology

Source 1: https://www.frontiersin.org/articles/10.3389/fmech.2020.589171/full
Source 2: https://singularityhub.com/2009/12/03/organovo-has-its-first-commercial-3d-bioprinter/

PRICING DETAILS

USD 1,899

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
sales@rootsanalysis.com